1553 EARLY IHDOMETHACIN (IND) DOES NOT PREVENT BRONCHOPULMONARY DYSPLASIA (BPD) IN A RANDOMIZED CLINICAL TRIAL

Thirty infants < 1500 g at birth on IPPB or CPAP by 12 hours were entered in a randomized double blind controlled trial to test the efficacy of IND in preventing BPD. 15 treated infants received IND at 12, 24 and 36 hours of age while 15 control infants received normal saline at these times. The groups were similar for birth weight, gestational age and sex.